Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : ajtj's Post-Lobotomy Market Charts and Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Sun Tzu who wrote (82768)	11/11/2023 11:52:46 AM
From: Lee Lichterman III	2 Recommendations Recommended By ajtj99 JSD Read Replies (1) \| Respond to of 97457

PSTX is the only biotech that doesn't look horrible to me. Didn't look into it in depth but they aren't relying on only one product, have many prospects in phase one trials and appear to have spending under control and cash to last a little while. Of course only in phase one means years before anything goes into release if it makes it all the way through to FDA approval. QRTEP looks like it runs to ex div then dies for the next month. If it had options, it would have been a no brainer to buy 2-3 month puts at the top channel line a week or so before op ex to minimize time erosion and then ride it down. Unfortunately like I said, no options on it. Might be able to short it after the ex date. Not sure. TRUP could still be a good short but a couple days ago would have been better. I already have oversold signals on it now. I haven't looked into it much yet. Looks like they are seeing accelerating cash burn and as people use up their excess savings, they'll be scaling back on pet spending. Shelters around here are all overflowing already.